NM_000143.4:c.1237-7_1237-4dupCTCA

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6

The NM_000143.4(FH):​c.1237-7_1237-4dupCTCA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000222 in 1,440,600 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000051 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

FH
NM_000143.4 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.123

Publications

0 publications found
Variant links:
Genes affected
FH (HGNC:3700): (fumarate hydratase) The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]
FH Gene-Disease associations (from GenCC):
  • hereditary leiomyomatosis and renal cell cancer
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • fumaric aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pheochromocytoma-paraganglioma
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • leiomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP6
Variant 1-241500593-T-TTGAG is Benign according to our data. Variant chr1-241500593-T-TTGAG is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 413608.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000143.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FH
NM_000143.4
MANE Select
c.1237-7_1237-4dupCTCA
splice_region intron
N/ANP_000134.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FH
ENST00000366560.4
TSL:1 MANE Select
c.1237-7_1237-4dupCTCA
splice_region intron
N/AENSP00000355518.4
FH
ENST00000682567.1
n.4630_4633dupCTCA
non_coding_transcript_exon
Exon 7 of 8
FH
ENST00000683521.1
c.1237-7_1237-4dupCTCA
splice_region intron
N/AENSP00000506864.1

Frequencies

GnomAD3 genomes
AF:
0.0000511
AC:
4
AN:
78214
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000133
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000297
Gnomad SAS
AF:
0.000483
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000269
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000172
AC:
4
AN:
233054
AF XY:
0.0000316
show subpopulations
Gnomad AFR exome
AF:
0.0000675
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000571
Gnomad FIN exome
AF:
0.0000577
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000206
AC:
28
AN:
1362310
Hom.:
0
Cov.:
33
AF XY:
0.0000235
AC XY:
16
AN XY:
680700
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000628
AC:
2
AN:
31848
American (AMR)
AF:
0.0000456
AC:
2
AN:
43888
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25022
East Asian (EAS)
AF:
0.000234
AC:
9
AN:
38430
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84086
European-Finnish (FIN)
AF:
0.0000829
AC:
4
AN:
48276
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4854
European-Non Finnish (NFE)
AF:
0.00000874
AC:
9
AN:
1029478
Other (OTH)
AF:
0.0000354
AC:
2
AN:
56428
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.277
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000511
AC:
4
AN:
78290
Hom.:
0
Cov.:
27
AF XY:
0.0000535
AC XY:
2
AN XY:
37354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
19784
American (AMR)
AF:
0.000133
AC:
1
AN:
7528
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2280
East Asian (EAS)
AF:
0.000298
AC:
1
AN:
3358
South Asian (SAS)
AF:
0.000484
AC:
1
AN:
2066
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
176
European-Non Finnish (NFE)
AF:
0.0000269
AC:
1
AN:
37198
Other (OTH)
AF:
0.00
AC:
0
AN:
1100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Aug 22, 2024
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The FH c.1237-7_1237-4dup variant has not been reported in individuals with FH-related conditions in the published literature. The frequency of this variant in the general population, 0.000017 (4/233054 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on FH mRNA splicing yielded inconclusive findings. Based on the available information, we are unable to determine the clinical significance of this variant.

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary cancer-predisposing syndrome Benign:1
Sep 22, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.12
Mutation Taster
=96/4
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750898743; hg19: chr1-241663893; API